- Meyer RE. New pharmacotherapies for cocaine dependence.. revisited. Arch Gen Psychiatry. 1992;49:900-904.
- Kosten TR. Pharmacotherapies. In: Kosten TR, Kleber HD, eds. Clinician's Guide to Cocaine Addic lion: Theory Research and Treatment New York: Guilford Press; 1992:273-289.
- O'Brien CP. Clinical trials methodology. Paper presented at Plenary Session. Drug Development 10 Treat Addictive Disorders. American College of Neuropsychopharmacology Annual Meeting. December. 1993
- Nunes EV. Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective. NIDA Monograph 175. Washington, DC: 1997:73-95.
- Klein DF. Improvements of phase 111 psychotropic drug trials by intensive phase Il work. Neuropsy chopharm. 1991;4:251-258.
- Carroll KM. Manual guided psychotherapy as an adjunct to pharmacotherapy trials. Arch Gen Psych. 1997.54:923-928.
- Physicians Desk Reference. Montvale, New Jersey: Medical Economics Company at Montvale; 1996.
- Nakajima S. Subtype's of dopamine receptors involved in the mechanism of reinforcement. The neural basis of reward and reinforcement: a conference in honour of Peter M. Milner. Neurosci Biobebav Rev. 1991; 13(special issue):123-128.
- Baker LE, Riddle EE, Saunders RB. et al. The role of monoamine uptake in the discriminative stimulus of cocaine and related compounds. Behav Phar marmacol. 1993;4:69-79.
- Volkow ND, Fowler JS, Wang G-J. et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse, 1993;14:169-177.
- Volkow ND, Wang GJ, Folwer JS. et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997;386:830-833
- Malcolm R, Hullo BR, Phillips PAC. et al. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry, 1991;52:39-40.
- Malcolm R, Phillips JD, Brady KT. et al. A comparison of pergolide and bromocriptine in the initial rehabilitation of cocaine dependence. Am J Addict. 1994;3:144-150.
- Gawin FJ, Kleber HD. Cocaine abuse treatment: open trial with desipramine and lithium carbonate. Arch Gen Psychiatry. 1984;42:903-910.
- Morgan CH, Kosten TR, Gawin FH. et al. A pilot trial of amantadine for cocaine abuse. NIDA Research Monograph No. 81. Washington, DC: U.S. Government Printing Office; 1997:81-85.
- Berger PA, Gawin FH, Kosten TR. Treatment of cocaine abuse with mazindol. Lancet. 1989;1:283.
- Margolin A, Kosten TR, Petrakis IL. et al. Bupropion reduces cocaine abuse in methadone-maintained patients. Arch Gen Psychiatry 1991;18:87.
- Kosten TR, Schumann B, Wright D. et al. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry, 1987;48:442-444.
- Malcolm R, Brady K, Moore J. et al. Dose-response effects of pergolide in the treatment of cocaine dependence. Paper presented at: Oral Communications Session. College on Problems of Drug Dependence Annual Meeting. Scottsdale. Ariz; June 13-18, 1998.
- Malcolm R, Moore JW, Kajdasz DK. et al. Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997;6:117-123.
- Nunes EV, McGrath PJ, Stewart FM. Bromocriptine treatment for cocaine addiction. Am J Addict. 1993;2:169-172.
- Dackis CA, Gold MS, Sweeney DR. et al. Single-dose bromocritine reverses cocaine craving. Psy chiatr Res. 1987;20:261-264.
- Giannini AJ, Baumgartel P. Bromocriptine-desipramine protocol in treatment of cocaine addiction. J Clin Pharm. 1987;27:549-554.
- Self DW, Bamhart WJ, Lehrman DA. et al. Opposite modulation of cocaine-seeking behavior by D1 and D2-like dopamine receptor agonists. Science. 1996;271:1586-1589.
- Haney M, Foltin RW, Fischman MW. Effectsof pergolide on intravenous cocaine self-administration in men and women. Psychopharm. 1998;137:15-24.
American Journal on Addictions
Volume 8, 1999 - Issue 2